James Hippel is CFO at BIO-TECHNE Corp (TECH). They have made 13 open-market trades across 1 company since 2019, most recently 2026-08-15.
CIK 0001603594
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 13 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TECH | 170,183 | $12.3M |
Shares reported on the most recent Form 4, priced at the 2026-08-18 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TECH | SELL | 2021-11-01 | 2021-11-03 | $526.51 | $7.9M | -0.8% | -9.8% | -20.6% |
| TECH | SELL | 2021-10-28 | 2021-11-01 | $525.22 | $800K | -2.5% | -11.1% | -27.6% |
| TECH | SELL | 2021-09-02 | 2021-09-07 | $507.22 | $10.1M | +5.1% | -3.9% | -7.9% |
| TECH | SELL | 2021-08-09 | 2021-08-10 | $478.90 | $4.8M | +3.0% | +9.2% | +8.8% |
| TECH | SELL | 2021-07-12 | 2021-07-14 | $456.40 | $8.0M | +6.2% | +5.0% | +7.5% |
| TECH | SELL | 2021-06-07 | 2021-06-09 | $421.63 | $6.8M | +2.4% | +8.2% | +19.6% |
| TECH | SELL | 2021-02-12 | 2021-02-17 | $400.39 | $4.0M | -8.5% | -7.8% | -1.7% |
| TECH | SELL | 2021-01-11 | 2021-01-13 | $333.89 | $6.2M | +2.4% | +20.0% | +26.2% |
| TECH | SELL | 2020-11-09 | 2020-11-12 | $307.95 | $6.3M | -1.0% | +0.1% | +27.6% |
| TECH | SELL | 2020-11-04 | 2020-11-06 | $280.55 | $8.2M | -2.9% | -0.7% | +23.5% |
| TECH | SELL | 2020-07-06 | 2020-07-08 | $271.58 | $12.9M | +3.1% | -3.2% | -6.6% |
| TECH | SELL | 2019-11-21 | 2019-11-25 | $215.50 | $14.7M | -0.5% | -0.9% | -8.5% |
| TECH | SELL | 2019-05-01 | 2019-05-02 | $203.08 | $7.1M | -2.5% | -2.2% | +3.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.